Article: New York Times Article Threatens Highly Successful Narcolepsy Treatment and Angers Patients.

Byline: Narcolepsy Network

NORTH KINGSTOWN, R.I., July 2 (AScribe Newswire) -- The Narcolepsy Network today released the following statement.

- - - -

Just days before the manufacturer of the narcolepsy medication Xyrem made an initial public offering of its shares, the New York Times and two affiliates published an article that was both unnecessarily negative and blatantly misleading in its portrayal of Xyrem, a first-line treatment for narcolepsy. Narcolepsy patients expressed outrage over such negatively biased and unbalanced reporting, especially as it threatens to railroad the efforts of Narcolepsy Network and its members to educate the public about narcolepsy ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!